1.Prevalence of hepatitis viral markers in patients with hepatocellular carcinoma and extrahepatic neoplasm
Journal of Medical Research 2005;37(4):33-37
Objectives: studying the seroprevalence of HBsAg and anti-HCV in patients with hepatocellular carcinoma (HCC) and neoplasm of non-liver organs. Subjects and method: 124 patients with HCC and 284 patients with neoplasm of non-liver organs (i.e. stomach, colorectus and lung) were treated at Bach Mai Hospital and Viet Duc Hospital. This cross-sectional study was conductedfrom January 2002 to April 2003. Results: Out of 124 patients with HCC, HBsAg positive found in 95/124 (76.6%), anti- HCV positive found in 2/61 (3.28%), both HBsAg and anti-HCV posititive found in 1/61 (1.64%), and prevalence of anti-HCV is much lower than that of HBsAg, p<0.0001. Out of 284 patient with non-liver cancer, HBsAg posititive found in 33/284 (11.62%), and none among 179 patients has anti-HCV posititive. The prevalence of HBsAg posititive in HCC group is much higher than in non-liver cancer group (p<0.0001, OR=24.92).
Carcinoma, Hepatocellular, Neoplasms
2.Inferior vena cava and intra-cardiac invasion of hepatocellular carcinoma: a rare but catastrophic complication
Cynthia Assimta Peter ; Anand Swaroop Uppaluri ; Bak Siew Steven Wong
The Medical Journal of Malaysia 2017;72(1):58-59
Intra-cardiac extension of hepatocellular carcinoma (HCC) is
an uncommon but serious condition related to poor
prognosis. We report a 57-year-old male diagnosed with
HCC with intra-cardiac extension into the right atrium at
presentation. There were no symptoms related to cardiac
involvement and intra-cardiac extension was incidentally
noted on radiological imaging. He was offered palliative
treatment and succumbed to his disease within 50 days of
first diagnosis.
Carcinoma, Hepatocellular
;
Liver Neoplasms
3.The role of serum alpha feto-protein in the diagnosis and management of hepatocellular carcinoma
Journal of Practical Medicine 2003;458(8):42-45
Review and update some knowledge of alpha feto-protein (AFP) value in the diagnosis, prognosis and management of patients with hepatocellular carcinoma (HCC), and the role of AFP in monitoring of response to medical and surgical treatments. Serum AFP tests give sensitivity of 50% and specificity >90% at cut-off value of 500 ng/ml in the diagnosis of HCC in patients who had underlined hepatic diseases
Carcinoma, Hepatocellular
;
Liver
;
Liver Neoplasms
4.Sarcomatous hepatocellular carcinoma: Two case reports and a review of Korean clinical literature.
Chang Min LEE ; Tae Hyo KIM ; Hyun Ju MIN ; Hyun Jin KIM ; Woon Tae JUNG ; Ok Jae LEE ; Gyung Hyuck KO
Korean Journal of Medicine 2009;77(Suppl 1):S41-S47
Sarcomatous hepatocellular carcinoma (HCC) is a rare primary liver cancer. Pathogenesis of sarcomatous transformation of HCC has not yet been elucidated. Sarcomatous HCC has highly invasive and metastatic potential, compared with ordinary HCC. We present here two cases of sarcomatous hepatocellular carcinoma with an unfavorable prognosis. Other cases reported in Korean literature of this uncommon tumor were also reviewed.
Carcinoma, Hepatocellular
;
Liver Neoplasms
;
Prognosis
8.Expression of nm23 Protein in Human Gastric Carcinoma: correlation between nm23 expression with the development and metastasis of gastric carcinoma.
Jin Hee SOHN ; Hye Rym PARK ; Young Oui PARK
Korean Journal of Pathology 1996;30(6):487-494
Gene expression of nm23 has been investigated in many kinds of tumors, including breast cancers, colon cancers, hepatocellular carcinomas, papillary carcinomas of the thyroid and malignant melanomas since the nm23 was dislovered by Dr. Steeg as a tumor metastatic suppressor gene. Reduced expression of nm23 gene implicated in high metastatic potential in a variety of malignancies. However, there have been only a few reports on genetic alteration and expression of nm23 in human gastric carcinomas even though gastric carcinoma is a leading malignancy in Korea. In this study, we examined the expression of nm23 protein by immunohistochemistry in advanced and early gastric carcinomas, adenomas, matching normal mucosa to elucidate the role of nm23 in the development, progression and metastasis of human gastric carcinomas. The results are as follows; 1) Nm23 was expressed in 39 cases(69.6%) of 56 advanced gastric carcinomas. Among them, strong positive cases(grade 3) were 26(46.4%) and weak positive cases(grade 2) were 13(23.2%). 2) Nm23 expression was significantly different (P<0.05) depending on the site of the neoplasm. Antral carcinomas showed grade3 positivity in the 22/37 cases(60%), but carcinomas of the body showed negative (grade 1) result in about half(42.1%). 3) Nm23 expression was more intense in the neoplasm than normal mucosa.(67.9%) 4) Nm23 expression was not significantly related to the lymph node metastasis, invasion of lymphatics or veins and depth of invasion. 5) In the well differentiated carcinomas, grade3 were more common(64.0%). But in cases of signet ring cell carcinoma, many cases were negative(50.0%). 6) Nm23 expression rate and intensity was significantly increased from the normal mucosa to the gastric adenomas, early gastric carcinomas and advanced gastric carcinomas.
Humans
;
Carcinoma, Hepatocellular
;
Neoplasm Metastasis
;
Breast Neoplasms
9.Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines.
Radiation Oncology Journal 2016;34(3):160-167
In oncologic practice, treatment guidelines provide appropriate treatment strategies based on evidence. Currently, many guidelines are used, including those of the European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL-EORTC), National Comprehensive Cancer Network (NCCN), Asia-Pacific Primary Liver Cancer Expert (APPLE), and Korean Liver Cancer Study Group and National Cancer Centre (KLCSG-NCC). Although radiotherapy is commonly used in clinical practice, some guidelines do not accept it as a standard treatment modality. In this review, we will investigate the clinical practice guidelines currently used, and discuss the application of radiotherapy.
Carcinoma, Hepatocellular*
;
Liver
;
Liver Neoplasms
;
Radiotherapy*
10.Hepatoid Adenocarcinoma of Stomach: A case report.
Jung Weon SHIM ; Hye Kyung AHN ; Young Cheol LEE ; Joo Seop KIM ; Young Euy PARK
Korean Journal of Pathology 1994;28(6):666-668
A case of primary gastric carcinoma with patterns resembling those of hepatocellular carcinoma(HCC) is reproted. This patient who represented high serum alpha-fetoprotein(AFP) underwent a subtotal gastrectomy for stomach cancer and lobectomy of liver metastasis. The hepatoid component of the tumor was characterized by solid nests of large polygonal cells arranged in cords and trabeculae, with central nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm; single-nuclear giant cells were frequently noted. These tumor cells of stomach stained positive immunohistochemically for AFP, ACT(alpha-1-antitrypsin), AACT(alpha-1-antichy-motrypsin). Thus, this hepatoid gastric adenocarcinoma tumor cells demonstrated both morphologic and immunohistochemical features of partial differentiation to the HCC. Careful histologic examination in conjunction with the immunohistochemical demonstration of AFP can provide a useful contribution to the diagnosis of this rare histological type of gastric carcinoma And the presence of metastatic hepatoid adenocarcinoma from the stomach should be considered in a patient with hepatic tumor mimicking HCC. Because of frequent venous and lymphatic invasion, as well as liver metastasis, prognosis appears to be poor. The authors reviewed 45 cases of hepatoid adenocarcinoma of stomach reported in the literature, also.
Adenocarcinoma
;
Carcinoma, Hepatocellular
;
Neoplasm Metastasis
;
Stomach Neoplasms